AR070673A1 - Uso de la mequitazina en forma de racemato o de enantiomeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histaminicos h4 - Google Patents
Uso de la mequitazina en forma de racemato o de enantiomeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histaminicos h4Info
- Publication number
- AR070673A1 AR070673A1 ARP080105280A ARP080105280A AR070673A1 AR 070673 A1 AR070673 A1 AR 070673A1 AR P080105280 A ARP080105280 A AR P080105280A AR P080105280 A ARP080105280 A AR P080105280A AR 070673 A1 AR070673 A1 AR 070673A1
- Authority
- AR
- Argentina
- Prior art keywords
- azabicyclo
- phenothiazine
- oct
- ylmethyl
- involve
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title 1
- HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 229960005042 mequitazine Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000000543 Histamine Receptors Human genes 0.000 abstract 3
- 108010002059 Histamine Receptors Proteins 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- HOKDBMAJZXIPGC-MRXNPFEDSA-N 10-[[(3r)-1-azabicyclo[2.2.2]octan-3-yl]methyl]phenothiazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1C[C@@H]1C(CC2)CCN2C1 HOKDBMAJZXIPGC-MRXNPFEDSA-N 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- HOKDBMAJZXIPGC-INIZCTEOSA-N 10-[[(3s)-1-azabicyclo[2.2.2]octan-3-yl]methyl]phenothiazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1C[C@H]1C(CC2)CCN2C1 HOKDBMAJZXIPGC-INIZCTEOSA-N 0.000 abstract 1
- 201000004813 Bronchopneumonia Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 238000011861 anti-inflammatory therapy Methods 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 239000013066 combination product Substances 0.000 abstract 1
- 229940127555 combination product Drugs 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000003149 muscarinic antagonist Substances 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Uso de la 10-[(3R)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina, de la 10-[(3S)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina, o de la 10-[(3R,3S)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina o bien de una de sus sales farmacéuticamente aceptables para la preparacion de un medicamento destinado a prevenir o a tratar las patologías que implican los receptores histamínicos H4, seleccionados de entre: la dermatitis atopica, el prurito, las inflamaciones bronquiales tales como asma y bronconeumonia obstructiva. Reivindicacion 8: Uso segun una de las reivindicaciones anteriores, caracterizado porque el medicamento está destinado a prevenir o a tratar las patologías que implican los receptores histamínicos H4 y os receptores muscarínicos, de manera simultánea. Reivindicacion 16: Producto que contiene 10-[(3R)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina, 10-[(3S)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina o 10-[(3R,3S)-1-azabiciclo[2.2.2]oct-3-ilmetil]-10H-fenotiazina, o bien una de sus sales farmacéuticamente aceptables, así como un medicamento de la clase de los anti-histamínicos de tipo anti-H1, de los corticoides, de los anti-muscarínicos de corta o de larga duracion de accion y de los b2-miméticos, como producto de combinacion para un uso simultáneo, separado o espaciado en el tiempo, en una terapia anti-inflamatoria por antagonismo de los receptores histamínicos H4.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0759538A FR2924344B1 (fr) | 2007-12-04 | 2007-12-04 | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
| FR0854144A FR2924345B1 (fr) | 2007-12-04 | 2008-06-23 | Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070673A1 true AR070673A1 (es) | 2010-04-28 |
Family
ID=39522380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105280A AR070673A1 (es) | 2007-12-04 | 2008-12-04 | Uso de la mequitazina en forma de racemato o de enantiomeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histaminicos h4 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20100273752A1 (es) |
| EP (2) | EP2255811A1 (es) |
| JP (2) | JP2011505411A (es) |
| KR (1) | KR20100108347A (es) |
| CN (1) | CN101883566B (es) |
| AR (1) | AR070673A1 (es) |
| AU (1) | AU2008333220B2 (es) |
| BR (1) | BRPI0820652A2 (es) |
| CA (1) | CA2706898A1 (es) |
| CL (1) | CL2008003584A1 (es) |
| FR (2) | FR2924344B1 (es) |
| IL (1) | IL206073A0 (es) |
| MA (1) | MA31930B1 (es) |
| MX (1) | MX2010006139A (es) |
| NZ (1) | NZ586212A (es) |
| PA (1) | PA8805501A1 (es) |
| RU (1) | RU2510273C2 (es) |
| TN (1) | TN2010000241A1 (es) |
| TW (1) | TW200932242A (es) |
| WO (1) | WO2009071625A1 (es) |
| ZA (2) | ZA201004312B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2201982A1 (en) | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Histamine H4 receptor antagonists for the treatment of vestibular disorders |
| SI2858647T1 (sl) | 2012-06-08 | 2018-11-30 | Sensorion | Inhibitorji receptorja H4 za zdravljenje tinitusa |
| EP4163252A1 (en) * | 2021-10-06 | 2023-04-12 | Solvay SA | Method for purifying an aqueous hydrogen peroxide solution |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2440371A1 (fr) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer |
| FR2522660A1 (fr) * | 1982-03-05 | 1983-09-09 | Pharmuka Lab | Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant |
| JPS6330420A (ja) * | 1986-07-25 | 1988-02-09 | Sekisui Chem Co Ltd | 持続性抗アレルギ−固形塗布剤 |
| JP2735122B2 (ja) * | 1988-06-13 | 1998-04-02 | 旭化成工業株式会社 | メキタジンの液状シロップ製剤 |
| IT1251161B (it) * | 1991-08-07 | 1995-05-04 | Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono | |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| FR2822709B1 (fr) * | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
| DE10158036B4 (de) * | 2001-11-27 | 2007-05-03 | Kosmas Kg | Antiallergisches Mittel und dessen Verwendung |
| US20050090527A1 (en) * | 2003-01-28 | 2005-04-28 | Schering Corporation | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| JP2005060233A (ja) * | 2003-08-08 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| EP1526135A1 (en) * | 2003-10-24 | 2005-04-27 | Warner-Lambert Company LLC | Azabenzodiazepines as pde4 inhibitors |
| WO2005063253A1 (ja) * | 2003-12-26 | 2005-07-14 | Taiho Pharmaceutical Co., Ltd. | アレルギー症状治療用医薬組成物 |
| FR2896690B1 (fr) * | 2006-01-30 | 2008-05-02 | Pierre Fabre Medicament Sa | Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique |
-
2007
- 2007-12-04 FR FR0759538A patent/FR2924344B1/fr not_active Expired - Fee Related
-
2008
- 2008-06-23 FR FR0854144A patent/FR2924345B1/fr not_active Expired - Fee Related
- 2008-11-26 TW TW097145696A patent/TW200932242A/zh unknown
- 2008-11-27 PA PA20088805501A patent/PA8805501A1/es unknown
- 2008-12-01 CL CL2008003584A patent/CL2008003584A1/es unknown
- 2008-12-04 AU AU2008333220A patent/AU2008333220B2/en not_active Ceased
- 2008-12-04 JP JP2010536457A patent/JP2011505411A/ja active Pending
- 2008-12-04 CA CA2706898A patent/CA2706898A1/en not_active Abandoned
- 2008-12-04 WO PCT/EP2008/066787 patent/WO2009071625A1/en not_active Ceased
- 2008-12-04 EP EP10177151A patent/EP2255811A1/en not_active Withdrawn
- 2008-12-04 BR BRPI0820652A patent/BRPI0820652A2/pt not_active IP Right Cessation
- 2008-12-04 US US12/746,115 patent/US20100273752A1/en not_active Abandoned
- 2008-12-04 KR KR1020107013817A patent/KR20100108347A/ko not_active Ceased
- 2008-12-04 CN CN2008801188010A patent/CN101883566B/zh not_active Expired - Fee Related
- 2008-12-04 AR ARP080105280A patent/AR070673A1/es unknown
- 2008-12-04 NZ NZ586212A patent/NZ586212A/xx not_active IP Right Cessation
- 2008-12-04 MX MX2010006139A patent/MX2010006139A/es active IP Right Grant
- 2008-12-04 RU RU2010125711/15A patent/RU2510273C2/ru not_active IP Right Cessation
- 2008-12-04 EP EP08856761.5A patent/EP2227235B1/en active Active
-
2010
- 2010-05-28 TN TN2010000241A patent/TN2010000241A1/fr unknown
- 2010-05-30 IL IL206073A patent/IL206073A0/en unknown
- 2010-06-18 ZA ZA2010/04312A patent/ZA201004312B/en unknown
- 2010-06-22 MA MA32940A patent/MA31930B1/fr unknown
- 2010-10-26 ZA ZA2010/07626A patent/ZA201007626B/en unknown
-
2013
- 2013-12-04 JP JP2013251130A patent/JP2014065726A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2255811A1 (en) | 2010-12-01 |
| NZ586212A (en) | 2012-09-28 |
| FR2924345B1 (fr) | 2010-06-04 |
| KR20100108347A (ko) | 2010-10-06 |
| CN101883566A (zh) | 2010-11-10 |
| CL2008003584A1 (es) | 2009-05-22 |
| WO2009071625A1 (en) | 2009-06-11 |
| EP2227235A1 (en) | 2010-09-15 |
| AU2008333220B2 (en) | 2014-04-24 |
| CA2706898A1 (en) | 2009-06-11 |
| TN2010000241A1 (en) | 2011-11-11 |
| FR2924345A1 (fr) | 2009-06-05 |
| MX2010006139A (es) | 2010-10-15 |
| AU2008333220A1 (en) | 2009-06-11 |
| FR2924344B1 (fr) | 2010-04-16 |
| HK1148667A1 (en) | 2011-09-16 |
| FR2924344A1 (fr) | 2009-06-05 |
| TW200932242A (en) | 2009-08-01 |
| ZA201004312B (en) | 2011-02-23 |
| RU2010125711A (ru) | 2012-01-10 |
| EP2227235B1 (en) | 2014-11-12 |
| MA31930B1 (fr) | 2010-12-01 |
| PA8805501A1 (es) | 2009-12-16 |
| JP2011505411A (ja) | 2011-02-24 |
| RU2510273C2 (ru) | 2014-03-27 |
| US20100273752A1 (en) | 2010-10-28 |
| BRPI0820652A2 (pt) | 2019-09-10 |
| CN101883566B (zh) | 2013-03-06 |
| IL206073A0 (en) | 2010-11-30 |
| JP2014065726A (ja) | 2014-04-17 |
| ZA201007626B (en) | 2011-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6321265A2 (es) | Compuestos de 2-amido-3-metil pirrolo pirimidinona fenilo -sustituidos como inhibidores bace-1 composiciones y su uso | |
| CL2009000780A1 (es) | Compuestos derivados de heterociclil-pirano-heterociclilo, heterociclil-oxepina-heterociclilo, benzopirano-heterociclilo y benzoxepina-heterociclilo sustituidos; composicion farmaceutica; procedimiento de preparacion de la composicion; kit farmaceutico; y su uso en el tratamiento del cancer, mediado por la inhibicion de pi3k. | |
| BR112014014341A2 (pt) | Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica | |
| UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
| UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
| DOP2014000008A (es) | 4-imidazopiridazina-1-il-benzamidas y 4-imidazotriazina-1-il-benzamidas como inhibidores de btk | |
| BR112014001468A2 (pt) | compostos de tetra-hidropirido-piridina e tetra-hidropirido-pirimidina e uso dos mesmos como modulares do receptor c5a | |
| BR112013026355A2 (pt) | compostos de pirazolo[3,4-b]piridina tri- e tetracíclicos como agente antineoplásico | |
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| CL2012003212A1 (es) | Formas cristalinas i y ii de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado; procedimientos de preparacion; composicion farmaceutica; su procedimiento de preparacion; y su uso para el tratamiento de trastornos tales como trastorno por deficit de atencion y enfermedad de parkinson. | |
| BR112013025128A2 (pt) | derivados de pirrol como moduladores de receptor de acetilcolina nicotínico para uso no tratamento de distúrbios neurodegenenerativos tal como doença de alzheimer e doença de parkinson | |
| IN2014MN01571A (es) | ||
| HN2010002403A (es) | Derivados de quinuclidina como antagonistas de receptores muscarinicos m3 | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| EA201400064A1 (ru) | Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб | |
| BR112013026361A2 (pt) | derivados de glicosídeo e usos dos mesmos | |
| AR070673A1 (es) | Uso de la mequitazina en forma de racemato o de enantiomeros para la preparacion de un medicamento destinado al tratamiento o a la prevencion de patologias que implican los receptores histaminicos h4 | |
| MX2009006114A (es) | Composiciones que comprenden carisoprodol y metodos de uso de las mismas. | |
| BR112014004732A2 (pt) | composto benzotiazolona | |
| CL2016001707A1 (es) | Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11). | |
| AR080527A1 (es) | Una pirimidina sustituida como un antagonista del receptor de la postaglandina d2 | |
| ECSP088588A (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada | |
| MX2014010989A (es) | Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiatricos. | |
| BR112013025410A2 (pt) | tratamento terapêutico | |
| BR112014015314A8 (pt) | composição farmacêutica não entérica compreendendo crofelemer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |